logo
logo

Kayo Thera announced it raised $10.5 Million in an amended filing from an offering of $10.9 Million

Jul 13, 2023about 2 years ago

Amount Raised

$10.5 Million

PrincetonTherapeuticsBiotechnologyHealth Care

Company Information

Company

KayoThera, Inc.

Location

155 VILLAGE BLVD., SUITE 130

Princeton, West Virginia, United States

About

KayoThera, Inc. is an early-stage therapeutics company focused on the development of first-in-class, oral, small molecule inhibitors of the retinoid pathway. This pathway plays a critical role in a variety of serious diseases, including cardiometabolic diseases and cancer. KayoThera is developing therapies to treat diabetes and late-stage and metastatic cancers including breast, lung, pancreatic, colorectal, brain, and kidney cancers. The company was founded based on discoveries from Dr. Mark Esposito’s post-doctoral research at Princeton University and professor Yibin Kang, Ph.D. For more information, visit www.kayothera.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People